These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 36974812)
1. The Regulatory Role of Nuclear Respiratory Factor 1 in Bladder Cancer Cells. Lee YH; Wu RC; Mai HC; Huang WL; Wu CH; Yang YL; Hsieh PF; Lin VC Anticancer Res; 2023 Apr; 43(4):1521-1531. PubMed ID: 36974812 [TBL] [Abstract][Full Text] [Related]
2. Verbascoside inhibits the epithelial-mesenchymal transition of prostate cancer cells through high-mobility group box 1/receptor for advanced glycation end-products/TGF-β pathway. Wu CH; Chen CH; Hsieh PF; Lee YH; Kuo WW; Wu RC; Hung CH; Yang YL; Lin VC Environ Toxicol; 2021 Jun; 36(6):1080-1089. PubMed ID: 33522686 [TBL] [Abstract][Full Text] [Related]
3. HMGB1 attenuates TGF-β-induced epithelial-mesenchymal transition of FaDu hypopharyngeal carcinoma cells through regulation of RAGE expression. Li Y; Wang P; Zhao J; Li H; Liu D; Zhu W Mol Cell Biochem; 2017 Jul; 431(1-2):1-10. PubMed ID: 28285361 [TBL] [Abstract][Full Text] [Related]
4. Nuclear Respiratory Factor 1 Overexpression Inhibits Proliferation and Migration of PC3 Prostate Cancer Cells. Wu CH; Hsieh PF; Lee YH; Kuo WW; Wu RC; Lin YY; Hung CH; Hsieh ML; Pang ST; Yang YL; Lin VC Cancer Genomics Proteomics; 2022; 19(5):614-623. PubMed ID: 35985685 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition. Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492 [TBL] [Abstract][Full Text] [Related]
7. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer. Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma. Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366 [TBL] [Abstract][Full Text] [Related]
9. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling. Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells. Li W; Kidiyoor A; Hu Y; Guo C; Liu M; Yao X; Zhang Y; Peng B; Zheng J Tumour Biol; 2015 Feb; 36(2):1155-62. PubMed ID: 25722217 [TBL] [Abstract][Full Text] [Related]
11. HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells. Cheng M; Liu H; Zhang D; Liu Y; Wang C; Liu F; Chen J Am J Nephrol; 2015; 41(3):257-66. PubMed ID: 25924590 [TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma. Zhu L; Li X; Chen Y; Fang J; Ge Z Cancer Lett; 2015 Feb; 357(2):527-34. PubMed ID: 25511739 [TBL] [Abstract][Full Text] [Related]
13. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related]
14. High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro. Pang X; Zhang Y; Zhang S Oncol Rep; 2017 Feb; 37(2):831-840. PubMed ID: 28000879 [TBL] [Abstract][Full Text] [Related]
15. HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin. Zhang G; Chen F; Cao Y; Amos JV; Shah G; See WA J Urol; 2013 Sep; 190(3):1076-82. PubMed ID: 23353043 [TBL] [Abstract][Full Text] [Related]
16. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353 [TBL] [Abstract][Full Text] [Related]
17. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer. Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665 [TBL] [Abstract][Full Text] [Related]
18. High-mobility group box-B1 (HMGB1) mediates the hypoxia-induced mesenchymal transition of osteoblast cells via activating ERK/JNK signaling. Qiu Y; Chen Y; Zeng T; Guo W; Zhou W; Yang X Cell Biol Int; 2016 Nov; 40(11):1152-1161. PubMed ID: 27106169 [TBL] [Abstract][Full Text] [Related]
19. Highly Expressed LINC00958 Modulates the Growth and Epithelial-Mesenchymal Transition of Bladder Cancer Cells Through Xiao Y; He L; Dong Y; Huang Y; Ma L; Li W Cancer Biother Radiopharm; 2023 Aug; 38(6):405-414. PubMed ID: 35766943 [No Abstract] [Full Text] [Related]
20. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition. Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]